Biohaven Pharmaceutical Holding Company Ltd said on Tuesday two doses of its experimental treatment for acute migraine were effective in reducing headaches in a pivotal study.
Biohaven Pharmaceutical Holding said its migraine treatment met the main goals in two late-stage studies but the efficacy data failed to differentiate when compared...